Searchable abstracts of presentations at key conferences in endocrinology

ea0004oc5 | Growth regulation and development | SFE2002

27 YEARS ON - IMPROVED FINAL HEIGHT WITH GROWTH HORMONE THERAPY AFTER IRRADIATION FOR CHILDHOOD BRAIN TUMOURS REFLECTING EVOLVING ENDOCRINE PRACTICE

Stoeter R , Gleeson H , Ogilvy-Stuart A , Shalet S

Final height outcome is important in survivors of childhood brain tumours. Growth hormone replacement is indicated in those found to be GH deficient (GHD). More recently, GnRH analogues (GnRHa) have been introduced to delay early or rapidly progressing puberty. Studies to final height are important to determine the effectiveness of growth promoting strategies.SUBJECTS & METHODS Final height results in children receiving GH replacement for radiation i...